Artwork

Innhold levert av The PJ Pod and Pharmaceutical Journal. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The PJ Pod and Pharmaceutical Journal eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Can antiviral drugs turn the tide on COVID-19?

31:51
 
Del
 

Manage episode 323237385 series 3329558
Innhold levert av The PJ Pod and Pharmaceutical Journal. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The PJ Pod and Pharmaceutical Journal eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
There have been claims that COVID-19 oral antivirals, such as molnupiravir and Paxlovid (nirmatrelvir + ritonavir), will “change the course of the pandemic”. But with limited supply, a short treatment window and only a few patient groups eligible to receive them — can these drugs really turn things around? In this episode, Dawn Connelly, features editor, and Julia Robinson, clinical and science editor, answer questions from PJ readers on how they will be used in practice. They are joined by Penny Ward, visiting professor in pharmaceutical medicine at King’s College London, and Fiona Marra, a consultant infectious disease pharmacist based in Scotland. Thank you to Rob Ardley, Nicola Vasey, Umeh Ali and Gareth Malson for their questions. This episode was produced by Geoff Marsh.
  continue reading

42 episoder

Artwork
iconDel
 
Manage episode 323237385 series 3329558
Innhold levert av The PJ Pod and Pharmaceutical Journal. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The PJ Pod and Pharmaceutical Journal eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
There have been claims that COVID-19 oral antivirals, such as molnupiravir and Paxlovid (nirmatrelvir + ritonavir), will “change the course of the pandemic”. But with limited supply, a short treatment window and only a few patient groups eligible to receive them — can these drugs really turn things around? In this episode, Dawn Connelly, features editor, and Julia Robinson, clinical and science editor, answer questions from PJ readers on how they will be used in practice. They are joined by Penny Ward, visiting professor in pharmaceutical medicine at King’s College London, and Fiona Marra, a consultant infectious disease pharmacist based in Scotland. Thank you to Rob Ardley, Nicola Vasey, Umeh Ali and Gareth Malson for their questions. This episode was produced by Geoff Marsh.
  continue reading

42 episoder

Alle episoder

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett